Ignite Creation Date:
2024-05-06 @ 6:51 PM
Last Modification Date:
2025-12-16 @ 9:28 PM
Study NCT ID:
NCT05814627
Status:
None
Last Update Posted:
2025-12-12 00:00:00
First Post:
2023-04-04 00:00:00
Brief Title:
Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib Compared to Subcutaneous Adalimumab in Adult Participants With Moderate to Severe Rheumatoid Arthritis
Sponsor:
AbbVie
Organization:
AbbVie